Mackay Shields LLC Spectrum Pharmaceuticals Inc Transaction History

Mackay Shields LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$1.83 - $3.45 $233,872 - $440,906	-127,799 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$3.5 - $10.35 $57,050 - $168,705	-16,300 Reduced 11.31%	127,799 $465,000
Q3 2019 Nov 01, 2019	BUY	$7.03 - $9.7 $144,115 - $198,849	20,500 Added 16.59%	144,099 $1.2 Million
Q2 2019 Aug 13, 2019	BUY	$7.36 - $11.26 $624,841 - $955,940	84,897 Added 219.36%	123,599 $1.07 Million
Q1 2019 May 13, 2019	BUY	$9.08 - $11.84 $43,584 - $56,832	4,800 Added 14.16%	38,702 $413,000
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $16,582 - $44,089	-2,595 Reduced 7.11%	33,902 $297,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $39,648 - $59,568	2,400 Added 7.04%	36,497 $613,000
Q1 2018 May 03, 2018	BUY	$16.09 - $23.07 $548,620 - $786,617	34,097 New	34,097 $549,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.